Tag: myocardial infarction

Meet the Patients Who Helped Run a Big Aspirin Trial

When Tom McCormick got an unexpected call from his doctor, the first thing his doctor said was, “I’m not calling you about anything about your...

Spouses Can Share Cardiac Event Risk

A study from Japan suggests that a history of cardiovascular (CV) events in a spouse may elevate risk for future CV events in the other...

CTA May Guide Primary Prevention Statins in Nonobstructive CAD

The relative risk of death or myocardial infarction (MI) went down with statin therapy in a cohort study of patients with either nonobstructive coronary artery...

Political Support of Permanent DST Concerns Sleep Scientists

The reintroduction of congressional bills that aim to end seasonal time change and move permanently to daylight saving time (DST) – and action on the...

South Asian Ancestry Linked to Increased Risk for Heart Disease

Individuals of South Asian ancestry face twice the risk of heart disease, compared with individuals of European descent, yet existing risk calculators fail to account...

Midlife Change in Wealth May Be Costly for Heart Health

Midlife changes in wealth may affect a patient’s risk of cardiovascular disease, a new cohort study suggests. It found that upward wealth mobility relative to...

Bariatric Surgery’s Cardiovascular Benefit Extends to 7 Years

Patients with obesity who had bariatric surgery had a lower risk of having a major adverse cardiovascular event (MACE) or dying from all causes during...

Blood Sugar Control in Diabetes Is Getting Worse

Fewer adults with diabetes in the United States have well-controlled blood sugar or blood pressure now compared to 10 years ago, a trend that should...

Genotype-Guided Antiplatelet Therapy Misses Mark

The observational extended study of the previously reported 12-month randomized TAILOR-PCI trial shows genotype-guided antiplatelet therapy after percutaneous coronary intervention (PCI) did not significantly reduce...

Colorado Lawmakers Wage Multifront Assault on High Drug Costs

DENVER — Tired of waiting for federal action to reduce prescription drug costs, Colorado is acting on its own — even if it must do...

Switching From Ticagrelor to Clopidogrel Safe Post-PCI

New support for replacing higher-potency ticagrelor (Brilinta) with clopidogrel as part of dual-antiplatelet therapy (DAPT) 30 days after stenting for acute myocardial infarction comes from...

Paclitaxel Devices Exonerated in Real-World Data

A cohort analysis using advanced strategies to minimize the impact of confounders has concluded that the current Food and Drug Administration warning about paclitaxel-coated devices...

BP Lowering Useful in CV Risk Management Even at Normal Levels

Lowering blood pressure with antihypertensive medication protects against future cardiovascular (CV) events even in people with normal or only mildly elevated blood pressure, a large...

Is it Type 2 MI or a Nonischemic Imposter?

Survival gains in the management of acute myocardial infarction (MI) in recent decades don’t apply to one increasingly common category of MI. Type 2 MI, triggered...

Physical Activity at Leisure, Not Work, Tied to Health Benefits

Leisure time physical activity and physical activity performed at work have opposite associations with cardiovascular health and mortality, according to results of an observational study...

Arthritis Drug May Curb Myocardial Damage in Acute STEMI

Early use of tocilizumab (Actemra) does not reduce myocardial infarct size but modestly increases myocardial salvage in patients with acute ST-segment elevation myocardial infarction (STEMI),...

Long Work Hours Tied to Double the Risk for Recurrent MI

Patients who work upward of 55 hours per week after a myocardial infarction (MI) may increase their risk of having a recurrence, a new study...

Target-Lesion Failure Reduced After MI With Biodegradable Stent

For a primary composite target-lesion failure outcome, a biodegradable polymer sirolimus-eluting stent showed superiority at 2 years over a durable polymer everolimus-eluting stent in patients...

Missed Visits During Pandemic Cause ‘Detrimental Ripple Effects’

More than one third of adults aged 18-64 years in the United States delayed or went without medical care because of efforts by patients or...

New Light Cast on Type-2 MI Aims to Sharpen Diagnosis, Therapy

The hospital and post-discharge course of patients diagnosed with type-2 myocardial infarction (MI), triggered when myocardial oxygen demand outstrips supply, differs in telling ways from...

Radial-to-Backup Artery Switch Adds Limited Risk in ACS PCI

There’s a price to pay for a failed radial artery attempt in invasively managed patients with acute coronary syndrome (ACS), but it may not be...

Carotid Surgery Still Too Risky With Contralateral Occlusion

Patients selected for carotid revascularization who have a contralateral carotid occlusion are still best triaged toward stenting rather than surgery, a new registry analysis suggests....

More Evidence Supports Early Anticoagulation in COVID-19

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Early initiation of prophylactic anticoagulation in COVID-19 patients newly admitted to...

GME Funding Tied to Better Outcomes, Resident Scores

Graduate medical education (GME) funding is linked with better patient outcomes and resident academic performance but did not boost hospitals’ bottom line, according to an...

Tofacitinib for RA Misses the Mark in Safety Study

Daily treatment with tofacitinib (Xeljanz) led to more malignancies and adverse cardiovascular events in older rheumatoid arthritis patients compared with treatment with a tumor necrosis...